z-logo
Premium
An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation
Author(s) -
NogueiraRodrigues Angelica,
Bukowski Alexandra,
Paulino Eduardo,
St. Louis Jessica,
Barrichello Adriana,
Sternberg Cinthya,
Gifoni Markus A. C.,
Luciani Silvana,
Goss Paul E.
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30647
Subject(s) - medicine , papanicolaou stain , latin americans , human papillomavirus , vaccination , vigilance (psychology) , low and middle income countries , human papillomavirus vaccine , environmental health , cervical cancer , economic growth , developing country , virology , cancer , political science , psychology , neuroscience , law , economics , gardasil
Human papillomavirus vaccine programs run the risk of repeating the problems associated with Papanicolaou testing programs in low‐income and middle‐income countries: an efficient, life‐saving tool that unfortunately is underused for cancer prevention. There is a great need for vigilance in the ongoing implementation of the human papillomavirus vaccine in Latin America.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here